Fluvoxamine-tricyclic antidepressant interaction. An accidental finding. 1991

G Bertschy, and S Vandel, and B Vandel, and G Allers, and R Volmat

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010091 Oximes Compounds that contain the radical R2C Aldoximes,Hydroxyimino Compounds,Ketoxime,Ketoximes,Oxime,Compounds, Hydroxyimino
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000929 Antidepressive Agents, Tricyclic Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. Antidepressants, Tricyclic,Tricyclic Antidepressant,Tricyclic Antidepressant Drug,Tricyclic Antidepressive Agent,Tricyclic Antidepressive Agents,Antidepressant Drugs, Tricyclic,Agent, Tricyclic Antidepressive,Agents, Tricyclic Antidepressive,Antidepressant Drug, Tricyclic,Antidepressant, Tricyclic,Antidepressive Agent, Tricyclic,Drug, Tricyclic Antidepressant,Drugs, Tricyclic Antidepressant,Tricyclic Antidepressant Drugs,Tricyclic Antidepressants
D016666 Fluvoxamine A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS. DU-23000,Desiflu,Dumirox,Faverin,Fevarin,Floxyfral,Fluvoxadura,Fluvoxamin AL,Fluvoxamin Stada,Fluvoxamin beta,Fluvoxamin-neuraxpharm,Fluvoxamin-ratiopharm,Fluvoxamina Geminis,Fluvoxamine Maleate,Fluvoxamine Maleate, (E)-Isomer,Fluvoxamine, (Z)-Isomer,Luvox,Novo-Fluvoxamine,Nu-Fluvoxamine,PMS-Fluvoxamine,ratio-Fluvoxamine,DU 23000,DU23000,Fluvoxamin neuraxpharm,Fluvoxamin ratiopharm,Geminis, Fluvoxamina,Novo Fluvoxamine,Nu Fluvoxamine,PMS Fluvoxamine,ratio Fluvoxamine

Related Publications

G Bertschy, and S Vandel, and B Vandel, and G Allers, and R Volmat
December 1980, Neuropharmacology,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and R Volmat
January 2002, Neurosciences (Riyadh, Saudi Arabia),
G Bertschy, and S Vandel, and B Vandel, and G Allers, and R Volmat
July 1991, Journal of psychiatry & neuroscience : JPN,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and R Volmat
January 1983, British journal of clinical pharmacology,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and R Volmat
March 1990, Clinical pharmacy,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and R Volmat
August 2001, Nihon rinsho. Japanese journal of clinical medicine,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and R Volmat
May 1994, British heart journal,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and R Volmat
April 2018, Internal and emergency medicine,
G Bertschy, and S Vandel, and B Vandel, and G Allers, and R Volmat
May 2013, Presse medicale (Paris, France : 1983),
G Bertschy, and S Vandel, and B Vandel, and G Allers, and R Volmat
January 2010, Acta otorrinolaringologica espanola,
Copied contents to your clipboard!